Michal Ayalon

No más puestos en curso

59 años

Health Technology

Consumer Services

Perfil

Michal Ayalon worked as Vice President of Research and Development at Kamada Ltd. from 2019 to 2022.
Prior to that, she held the same position at Galmed Pharmaceuticals Ltd. in 2015-2016.
In 2018-2019, she was Head of Research and Development at 89Bio Ltd. Ayalon received her undergraduate, graduate, and doctorate degrees from Tel-Aviv University.

Antiguos cargos conocidos de Michal Ayalon.

Empresas	Cargo	Fin
KAMADA LTD.	Director Técnico/Científico/I+D	28/02/2022
89Bio Ltd. 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis	Director Técnico/Científico/I+D	01/01/2019
EOCENE LTD.	Director Técnico/Científico/I+D	01/01/2016

Ver el detalle de la experiencia de Michal Ayalon.

Formación de Michal Ayalon.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michal Ayalon.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Tel-Aviv University Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kamada Ltd. Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products	Health Technology
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures aramchol for non-alcoholic steatohepatitis	Health Technology
89Bio Ltd. 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis	Health Technology